Varicella-zoster virus (VZV) has been found to persistently infect the human rhabdomyosarcoma cell line A204. Infectious center assays and fluorescent antibody staining demonstrated continuous production of infectious VZV and viral antigen. The level of infection determined by fluorescent antibody staining was variable, and usually only a small percentage of the cells were capable of producing plaques in permissive fibroblasts. The extent of infection was similar in cell cultures passaged at split ratios of 1:2 or 1:10 and grown at 33 or 37°C. VZV recovered from A204 cells several months after establishment of the persistent infection had markedly increased syncytia-forming activity as compared with the parental VZV grown in human diploid fibroblast cells and the three monkey kidney-derived cell lines Vero, CV-1, and MA104. The expression of this altered phenotype continued after serial passage of the cell-associated virus in human diploid fibroblast and Vero cells. Consequently, we designated the reisolated VZV as plaque variant A. The buoyant densities of VZV plaque variant A and VZV DNAs in CsCl gradients were indistinguishable.
Varicella-zoster virus (VZV) has been found to persistently infect the human rhabdomyosarcoma cell line A204. Infectious center assays and fluorescent antibody staining demonstrated continuous production of infectious VZV and viral antigen. The level of infection determined by fluorescent antibody staining was variable, and usually only a small percentage of the cells were capable of producing plaques in permissive fibroblasts. The extent of infection was similar in cell cultures passaged at split ratios of 1:2 or 1:10 and grown at 33 or 37°C. VZV recovered from A204 cells several months after establishment of the persistent infection had markedly increased syncytia-forming activity as compared with the parental VZV grown in human diploid fibroblast cells and the three monkey kidney-derived cell lines Vero, CV-1, and MA104. The expression of this altered phenotype continued after serial passage of the cell-associated virus in human diploid fibroblast and Vero cells. Consequently, we designated the reisolated VZV as plaque variant A. The buoyant densities of VZV plaque variant A and VZV DNAs in CsCl gradients were indistinguishable.
Varicella-zoster virus (VZV), like other human herpesviruses, has a propensity for persisting in the host, most likely in a latent state, for many years after primary infection (12) . Studies of persistent infections with herpes simplex virus (2, 3, (13) (14) (15) and cytomegalovirus (4, 5, 19) in cell culture elucidated some fundamental mechanisms which allow these herpesviruses to persist and cause recurrent illnesses in humans. Analogous in vitro studies of VZV persistence have not been reported, primarily because VZV is both stringently cell associated and host cell restricted. As a result, little or no infectious VZV is spontaneously released. Significant numbers of infectious particles cannot be obtained by cell disruption of permissive human diploid embryo fibroblast (HDEF), epithelial, or melanoma cells (7, 12) . In a recent study, it was reported that VZV can persistently infect Epstein-Barr virus-transformed lymphoblastoid Raji cells (11) ; however, the interpretation of results with these cells is encumbered by the influence of a resident Epstein-Barr virus genome. cells, are of mesodermal origin. We found that VZV infection in these cells was self-limited rather than fully permissive or lytic. Consequently, a long-term persistent infection was established in the A204 cell culture. We designated this VZV-infected cell line VZV-A204. We also report in this paper that VZV obtained from the A204 cells induced a marked increase in syncytium formation in HDEF and several monkey kidney-derived cell lines as compared with parental VZV. We periodically screened for the presence of mycoplasmas by fluorescent staining with 4'-6' diamidino-2-phenylindole (17) .
The VZV isolate CaQu was originally obtained from Nathalie Schmidt, and was propagated by cell-associated passage of infected HDEF cells (10) . The persistent infection of A204 cells was initiated by mixing 2 x 106 trypsinized, VZV-infected HDEF cells displaying 100% cytopathic effects with an equal number of A204 cells. The mixed cells were centrifuged at 1,500 rpm for 5 min, incubated at room temperature for 30 min, and then seeded into a 75-cm2 plastic flask. The cells were passaged twice weekly at a 1:2 split ratio for 3 weeks and once weekly thereafter. All cell counting was done with a hemacytometer, and trypan blueexcluding cells were considered viable.
Infectious center and cell-free virus assays. Assay of the number of plaque-forming cells was performed in a manner similar to that previously described (9 5 min each in PBS, the conjugate, also diluted 1:10 in PBS, was incubated and rinsed in the same manner. Cover slips were mounted with glycerol-PBS (1:1). Cells were viewed in darkfield illumination with a Zeiss microscope with a highpressure mercury lamp. The percentage of VZV antigen-bearing cells was determined after counting 400 to 1,500 cells at 250x magnification.
DNA radiolabeling and CsCI buoyant density gradients. HDEF cells were infected with VZV recovered from A204 cells (VZVpvA) or parental VZV by mixing infected with uninfected HDEF cells as previously described (10) . When cell monolayers contained 80 to 100% cytopathic effects, [3H]thymidine (10 p.Ci/ml, 40 to 60 p.Ci/mmol) or [14C]thymidine (5 ,uCi/ml, 57 mCi/ mmol) was added to the culture medium, and radiolabeling was carried out for 18 to 36 h. Radiolabeled DNA was extracted from the infected cells by the method of Hirt (8) in a manner similar to that previously described by Iltis et al. (10) . Briefly, the cell monolayers were washed three times with Tris buffer (pH 7.2), and 4 ml of 10 mM Tris buffer (pH 8.0) containing 1 mM EDTA and 0.6% sodium dodecyl sulfate was added to the flask. The cell lysate was held at 37°C for 10 min before adding 5.0 M NaCl directly to the lysate, which was then gently poured into a 15-ml glass Corex tube and kept at 4°C for 12 to 18 h. The supernatant containing VZV DNA was separated from the precipitate by centrifugation at 17,000 x g for 45 min. Precipitable radioactivity was determined as described below for the CsCl gradient fractions. 3H-labeled VZVpvA DNA was cosedimented with 14C-labeled parental VZV DNA in a 5-ml CsCl gradient (starting density, 1.690 g/cm3) by centrifugation at 36,000 rpm in a fixed-angle 50.3 rotor. 3H-labeled VZVpvA and VZV DNAs sedimented with '4C-labeled HDEF cell DNA served as a control to establish that VZV DNA was not cell DNA. The buoyant density of VZV DNA was previously shown to be 1.705 g/cm3 as compared with a human cell DNA density of 1.700 g/cm3 (10) . Gradient fractions were dripped from the bottom of the tube onto Whatman filter paper disks. The filters were batch precipitated in cold 5% trichloroacetic acid and washed in 95% ethanol and then in acetone. Radioactivity was determined in a Beckman LS8000 liquid scintillation counter with Biofluor (New England Nuclear Corp. twice weekly at a 1:2 split ratio for 3 weeks. At this time, the FAS and infectious center assays indicated that a small number of VZV-infected cells were present in the cultures. At 6 weeks p.i. we determined the number of infected cells weekly by indirect FAS, infectious center assay, or both. The micrograph (Fig. 1) shows the prominent nuclear and cytoplasmic staining typical of smears of VZV-infected A204 cells. The extent of infection in VZV-A204 cultures was determined in a long-term study from 6 to 39 weeks p.i. The percentage of infectious centers never exceeded 10%, whereas FAS indicated that as many as 17 to 18% of the cells contained VZV antigen at 17 and 33 weeks p.i., respectively (Fig. 2) . FAS was the more sensitive assay for estimating the percentage of virus-infected cells (Fig. 2) . Cell-free VZV (approximately 2 x 103 to 8 x 103 PFU) was obtained by sonication of VZV-A204 cells at the times indicated. A cellfree virus yield of three logs was consistent with the low level of infection in VZV-A204 cells and with that which can be obtained in permissive HDEF cells (7) . Infectious cell-free VZV was released into the culture medium and was not detected in excess of 25 PFU/ml.
We performed several growth curve assays with VZV-A204 cells at various times p.i. There was no difference between the growth rate of VZV-A204 cells and of uninfected A204 cells whether seeded at 2.5 x 105 or 4 x 105 cells per ml (Fig. 3) . VZV-A204 and A204 cells seeded at these concentrations generally had a doubling time of 2 to 3 days.
The possibility of obtaining a higher level of VZV infection in VZV-A204 or A204 cells was examined. The (Fig. 4) (Fig. 2) . VZV-A204 cells are presently being maintained at a split ratio of 1:10, and low, fluctuating levels of infected cells have been demonstrable continuously for 20 months.
Interestingly, after week 7 of this study we were no longer able to detect infectious centers or antigen-containing cells in the original VZV-A204 cells which had been maintained for 39 weeks at a 1:2 split ratio (Fig. 2) (Fig. 6) . DNA obtained from VZVpvA at 7 months and 1 year p.i. (Fig. 6A and C, respectively) was indistinguishable in buoyant density from the parental VZV DNA. The radiolabeled DNA profiles ( VZV-A20411 VZVpvA and wild-type VZV did not grow well at 39°C in HDEF or Vero cells; however, the syncytial plaque phenotype of VZVpvA, although markedly reduced, was apparent at 39°C. Likewise, no significant differences in plaquing between VZVpvA and wild-type VZV were noted at 33°C (J. P. Iltis, unpublished data). The variant plaque phenotype was induced by VZVpvA but not by wild-type VZV in HDEF and in three monkey kidney cell lines. There are two possible explanations for the origin of this variant. (i) Some A204 cell-induced modification of VZV DNA may have occurred, or (ii) a unique VZV variant was selected from a heterogeneous population of virions in the original VZV inoculum. CsCl gradient analysis did not detect any difference in the buoyant density of VZVpvA and parental VZV DNAs; however, only a relatively gross genomic G-C variation would be detected by this procedure. Restriction endonuclease cleavage analysis of VZVpvA DNA, currently in progress, may indicate whether cleavage site alterations are present as a result of genomic variation. The increased formation of syncytia caused by VZVpvA is probably related to the production of a unique or modified virion glycoprotein necessary for cell fusion. Further studies with polyacrylamide gel electrophoresis of immunoprecipitates of VZVpvA-and wild-type VZV-coded glycoproteins should help to determine the nature of the variant VZV phenotype.
The VZV-A204 cell line is a useful model, heretofore unavailable, for studying the mechanism(s) of VZV persistence in cell culture. If significant levels of infection can be achieved in VZV-A204 cells, e.g., by phorbol ester or corticosteroid induction, then a convenient resource will be readily available for clinical and basic studies of this important human pathogen. We hope that additional studies with VZVpvA will contribute to our understanding of wild-type vzv.
